• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发用于艾滋病毒消毒和功能性治愈策略的进展。

Advancements in Developing Strategies for Sterilizing and Functional HIV Cures.

作者信息

Xu Wei, Li Haoyang, Wang Qian, Hua Chen, Zhang Hanzhen, Li Weihua, Jiang Shibo, Lu Lu

机构信息

Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Fudan University, Shanghai 200032, China.

Key Laboratory of Reproduction Regulation of NPFPC, SIPPR, IRD, Fudan University, Shanghai 200032, China.

出版信息

Biomed Res Int. 2017;2017:6096134. doi: 10.1155/2017/6096134. Epub 2017 Apr 26.

DOI:10.1155/2017/6096134
PMID:28529952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5424177/
Abstract

Combined antiretroviral therapy (cART) has been successful in prolonging lifespan and reducing mortality of patients infected with human immunodeficiency virus (HIV). However, the eradication of latent HIV reservoirs remains a challenge for curing HIV infection (HIV cure) because of HIV latency in primary memory CD4 T cells. Currently, two types of HIV cures are in development: a "sterilizing cure" and a "functional cure." A sterilizing cure refers to the complete elimination of replication-competent proviruses in the body, while a functional cure refers to the long-term control of HIV replication without treatment. Based on these concepts, significant progress has been made in different areas. This review focuses on recent advancements and future prospects for HIV cures.

摘要

联合抗逆转录病毒疗法(cART)已成功延长了人类免疫缺陷病毒(HIV)感染者的寿命并降低了死亡率。然而,由于HIV在初始记忆CD4 T细胞中的潜伏性,根除潜伏的HIV储存库仍然是治愈HIV感染(治愈HIV)的一项挑战。目前,两种类型的HIV治愈方法正在研发中:“灭菌治愈”和“功能性治愈”。灭菌治愈是指完全消除体内具有复制能力的前病毒,而功能性治愈是指在不进行治疗的情况下长期控制HIV复制。基于这些概念,不同领域已取得了重大进展。本综述重点关注HIV治愈方法的最新进展和未来前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61aa/5424177/3377b3d72d73/BMRI2017-6096134.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61aa/5424177/71ac26c418b4/BMRI2017-6096134.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61aa/5424177/3377b3d72d73/BMRI2017-6096134.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61aa/5424177/71ac26c418b4/BMRI2017-6096134.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61aa/5424177/3377b3d72d73/BMRI2017-6096134.002.jpg

相似文献

1
Advancements in Developing Strategies for Sterilizing and Functional HIV Cures.开发用于艾滋病毒消毒和功能性治愈策略的进展。
Biomed Res Int. 2017;2017:6096134. doi: 10.1155/2017/6096134. Epub 2017 Apr 26.
2
Viral latency and potential eradication of HIV-1.HIV-1 的病毒潜伏和潜在清除。
Expert Rev Anti Infect Ther. 2012 Aug;10(8):855-7. doi: 10.1586/eri.12.68.
3
Targeting the Latent Reservoir for HIV-1.针对 HIV-1 的潜伏储库。
Immunity. 2018 May 15;48(5):872-895. doi: 10.1016/j.immuni.2018.04.030.
4
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.HIV-1储存库:在抗病毒免疫反应和抗逆转录病毒疗法存在的情况下病毒持续存在的机制
Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665.
5
Finding a cure for HIV: will it ever be achievable?寻找治愈 HIV 的方法:这是否可能实现?
J Int AIDS Soc. 2011 Jan 24;14:4. doi: 10.1186/1758-2652-14-4.
6
Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.由广泛中和抗体的单链Fv引导的嵌合抗原受体T细胞可特异性有效地根除从接受抑制性联合抗逆转录病毒疗法的HIV-1感染个体分离出的CD4 + T淋巴细胞中潜伏激活的病毒。
J Virol. 2016 Oct 14;90(21):9712-9724. doi: 10.1128/JVI.00852-16. Print 2016 Nov 1.
7
The role of latency reversal agents in the cure of HIV: A review of current data.潜伏逆转剂在 HIV 治愈中的作用:对现有数据的综述。
Immunol Lett. 2018 Apr;196:135-139. doi: 10.1016/j.imlet.2018.02.004. Epub 2018 Feb 7.
8
HDAC inhibitors in HIV.HIV 中的组蛋白去乙酰化酶抑制剂。
Immunol Cell Biol. 2012 Jan;90(1):47-54. doi: 10.1038/icb.2011.95. Epub 2011 Nov 15.
9
Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies.HIV-1 感染精英控制者中的病毒储存库:对 HIV 治愈策略的影响。
EBioMedicine. 2020 Dec;62:103118. doi: 10.1016/j.ebiom.2020.103118. Epub 2020 Nov 10.
10
Regulation of human immunodeficiency virus-1 latency and its reactivation.人类免疫缺陷病毒1型潜伏状态的调控及其激活
Bull Mem Acad R Med Belg. 2008;163(6):355-64; discussion 364-5.

引用本文的文献

1
Advances in HIV Treatment and Vaccine Development: Emerging Therapies and Breakthrough Strategies for Long-Term Control.艾滋病治疗与疫苗研发进展:新兴疗法及长期控制的突破性策略
AIDS Res Treat. 2025 Jul 4;2025:6829446. doi: 10.1155/arat/6829446. eCollection 2025.
2
Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells.异维 A 酸可促进 CD4T 细胞中具有翻译能力的 HIV 潜伏储库的清除。
PLoS Pathog. 2024 Oct 14;20(10):e1012601. doi: 10.1371/journal.ppat.1012601. eCollection 2024 Oct.
3
Gaining momentum: stem cell therapies for HIV cure.

本文引用的文献

1
Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy.抗逆转录病毒和α4β7抗体治疗后SIV阳性猕猴的病毒学持续控制
Science. 2016 Oct 14;354(6309):197-202. doi: 10.1126/science.aag1276.
2
Barriers to HIV Cure.HIV 治愈障碍。
HLA. 2016 Oct;88(4):155-63. doi: 10.1111/tan.12867.
3
Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change.治疗性疫苗与HIV感染的免疫干预:范式转变
蓄势待发:用于 HIV 治愈的干细胞疗法。
Curr Opin HIV AIDS. 2024 Jul 1;19(4):194-200. doi: 10.1097/COH.0000000000000859. Epub 2024 Apr 26.
4
Emerging perspectives on RNA virus-mediated infections: from pathogenesis to therapeutic interventions.RNA病毒介导感染的新观点:从发病机制到治疗干预
World J Virol. 2023 Dec 25;12(5):242-255. doi: 10.5501/wjv.v12.i5.242.
5
CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice.CRISPR 编辑 CCR5 和 HIV-1 有助于在抗逆转录病毒药物抑制的感染 HIV 的人源化小鼠中消除病毒。
Proc Natl Acad Sci U S A. 2023 May 9;120(19):e2217887120. doi: 10.1073/pnas.2217887120. Epub 2023 May 1.
6
HIV cure: an acceptability scientific agenda.HIV 治愈:一个可接受的科学议程。
Curr Opin HIV AIDS. 2023 Jan 1;18(1):12-17. doi: 10.1097/COH.0000000000000771. Epub 2022 Nov 9.
7
Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors.为 HIV 打造功能性治愈方法:转录调控因子与抑制剂。
Viruses. 2022 Sep 7;14(9):1980. doi: 10.3390/v14091980.
8
A Toxin-Conjugated Recombinant Protein Targeting gp120 and gp41 for Inactivating HIV-1 Virions and Killing Latency-Reversing Agent-Reactivated Latent Cells.一种毒素偶联的重组蛋白,靶向 gp120 和 gp41,用于失活 HIV-1 病毒颗粒和杀死潜伏逆转剂激活的潜伏细胞。
mBio. 2022 Feb 22;13(1):e0338421. doi: 10.1128/mbio.03384-21. Epub 2022 Jan 18.
9
Targeting and Understanding HIV Latency: The CRISPR System against the Provirus.靶向与理解HIV潜伏:针对前病毒的CRISPR系统
Pathogens. 2021 Sep 28;10(10):1257. doi: 10.3390/pathogens10101257.
10
Novel Antiretroviral Therapeutic Strategies for HIV.新型抗 HIV 治疗策略。
Molecules. 2021 Aug 31;26(17):5305. doi: 10.3390/molecules26175305.
Curr Opin HIV AIDS. 2016 Nov;11(6):576-584. doi: 10.1097/COH.0000000000000324.
4
Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.由广泛中和抗体的单链Fv引导的嵌合抗原受体T细胞可特异性有效地根除从接受抑制性联合抗逆转录病毒疗法的HIV-1感染个体分离出的CD4 + T淋巴细胞中潜伏激活的病毒。
J Virol. 2016 Oct 14;90(21):9712-9724. doi: 10.1128/JVI.00852-16. Print 2016 Nov 1.
5
Development of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 Latency.开发减毒Tat蛋白作为特异性激活HIV-1潜伏感染的高效药物。
Mol Ther. 2016 Sep;24(9):1528-37. doi: 10.1038/mt.2016.117. Epub 2016 Jun 6.
6
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption.HIV-1抗体3BNC117在治疗中断期间可抑制人体病毒反弹。
Nature. 2016 Jul 28;535(7613):556-60. doi: 10.1038/nature18929. Epub 2016 Jun 22.
7
Challenges and strategies for the eradication of the HIV reservoir.根除艾滋病毒储存库的挑战与策略
Curr Opin Immunol. 2016 Oct;42:65-70. doi: 10.1016/j.coi.2016.05.015. Epub 2016 Jun 9.
8
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.使用单克隆抗体3BNC117进行的HIV-1治疗引发宿主针对HIV-1的免疫反应。
Science. 2016 May 20;352(6288):997-1001. doi: 10.1126/science.aaf0972. Epub 2016 May 5.
9
TALEN gene editing takes aim on HIV.转录激活样效应因子核酸酶(TALEN)基因编辑技术瞄准了艾滋病病毒。
Hum Genet. 2016 Sep;135(9):1059-70. doi: 10.1007/s00439-016-1678-2. Epub 2016 May 12.
10
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges.单次注射抗HIV-1抗体可抵御反复的SHIV攻击。
Nature. 2016 May 5;533(7601):105-109. doi: 10.1038/nature17677. Epub 2016 Apr 27.